We evaluated a genital herpes prophylactic vaccine containing herpes virus 2 (HSV-2) glycoproteins C (gC2) and D (gD2) to stimulate humoral immunity and UL19 (capsid protein VP5) and UL47 (tegument protein VP13/14) as T cell immunogens. were positive for HSV-2 DNA and latency-associated transcripts for 5/8 animals in the gC2/gD2 group and 2/8 animals in… Continue reading We evaluated a genital herpes prophylactic vaccine containing herpes virus 2